Filing Details
- Accession Number:
- 0001104659-17-052304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-16 20:32:18
- Reporting Period:
- 2017-08-16
- Filing Date:
- 2017-08-16
- Accepted Time:
- 2017-08-16 20:32:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356576 | Supernus Pharmaceuticals Inc | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1539215 | P. Padmanabh Bhatt | C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850 | Sr.vp Of Ip, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-16 | 3,709 | $45.23 | 17,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 24, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.0750 to $45.4750, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Billionaire Hedge Funds
